Bitterman Kevin sold IRON
September 1, 2026 · Form 4 insider transaction
Bitterman Kevin sold 58 shares of Disc Medicine, Inc. at $79.95 per share, a transaction worth $4.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Shares were sold pursuant to a Rule 10b5-1 trading plan adopted on July 30, 2026.; These shares are held by Atlas Venture Opportunity Fund II, L.P. ("Opportunity II"). The general partner of Opportunity II is Atlas Venture Associates Opportunity II, L.P. ("Associates II"). Atlas Venture Associates Opportunity II, LLC ("Associates II LLC") is the general partner of Associates II. The Reporting Person is a member of Associates II LLC and disclaims beneficial ownership of such securities held by Opportunity II, except to the extent of his pecuniary interest therein, if any.